Drug-induced rhabdomyolysis

Adverse Drug Reaction Bulletin

Volumn , Issue 196, 1999, Pages 747-750

  Collinson, H L ^a   Wheeler, D C ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; AMPHOTERICIN; ANALGESIC AGENT; ANESTHETIC AGENT; ANTILIPEMIC AGENT; BRONCHODILATING AGENT; CARBENOXOLONE; DIURETIC AGENT; HYPNOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; LAXATIVE; MACROLIDE; NEUROLEPTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; OPIATE; STATIN;

ACUTE KIDNEY FAILURE; BIOCHEMISTRY; CLINICAL FEATURE; COMA; COMPRESSION; HUMAN; HYPOKALEMIA; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUSCLE NECROSIS; RHABDOMYOLYSIS; SHORT SURVEY; SKELETAL MUSCLE;

EID: 0032803150     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-199906000-00001     Document Type: Short Survey

References (61)

1. Bywaters EGL, Beall D. Crash injuries with impairment of renal function. British Medical Journal 1941; 1: 427-32.
2. Thomas MAB, Ibels LS. Rhabdomyolysis and acute renal failure. Australian and New Zealand Journal of Medicine 1985; 15: 623-8.
3. Curry SC, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Annals of Emergency Medicine 1989; 18: 1068-84.
4. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine 1982; 61: 141-52.
5. Lane RJM, Mastaglia FL. Drug-induced myopathies in man. Lancet 1978; 2: 562-66.
6. Pederson TR, Berg K, Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian simvastatin survival study. Archives of Internal Medicine 1996; 156: 2085-92.
7. Boccuzzi TR, Bocanegra TS, Walker JF, Shapiro DR, Keegan ME. Long term safety and efficacy profile of simvastatin. American Journal of Cardiology 1991; 68: 1127-31.
8. Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. American Journal of Cardiology 1988; 62: 28J-34J.
9. Dujovne CA, Chremos AN, Pool JL, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. American Journal of Medicine 1991; 91 (suppl. 1B): 25S-30S.
10. Anon. Management of Hyperlipidaemia. Drug and Therapeutics Bulletin 1996; 34: 89-93.
11. Corpier CL, Jones PH, Suki WN, et al. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. Journal of the American Medical Association 1988; 260: 239-41.
12. East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA. Rhabdomyolysis in patients, receiving lovastatin after cardiac transplantation. New England Journal of Medicine 1988; 318: 47-8.
13. Norman DJ, Illingworth DR, Munson J, Hosenpud J. Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. New England Journal of Medicine 1988; 318: 46-7.
14. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. Journal of the American Medical Association 1990; 264: 71-5.
15. Berland Y, Vacher Coponat HV, Durand C, Baz M, Laugier R, Musso JL. Rhabdomyolysis with simvastatin use. Nephron 1991; 57: 365-6.
16. Reaven P, Witztum JL. Lovastatin, nicotinic acid and rhabdomyolysis. Annals of Internal Medicine 1988; 109: 597-8.
17. Lees RS, Lees AM. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole. New England Journal of Medicine 1995; 333: 664-5.
18. Ayanian JZ, Fuchs CS, Stone RM. Lovastatin and rhabdomyolysis. Annals of Internal Medicine 1988; 109: 682-3.
19. Grunden JW, Fisher KA. Lovastatin- induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. Annals of Pharmacotherapy 1997; 31: 859-63.
20. Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli WE. Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet 1998; 351: 1929-30.
21. Cheung AK, De Vault GA Jr, Gregory MC. A prospective study on the treatment of hypercholesterolemia with lovastatin in renal transplant recipients receiving cyclosporine. Journal of the American Society of Nephrology 1993; 3: 1884-91.
22. Gorriz JL, Sancho A, Alcoy E, Garcia-Ramose JL, Pallardo LM. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment. Nephrology, Dialysis, Transplantation 1995; 10: 2371-2.
23. Pierides AM, Alvarez-Ude F, Kerr DNS. Clofibrate-induced muscle damage in patients with chronic renal failure. Lancet 1975; 2: 1279-82.
24. Bedani PL, Perini L, Gilli P. Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis. Nephron 1994; 68: 512-13.
25. Devuyst O, Goffin E, Pirson Y, van Ypersele de Strihou CH. Creatinine rise after fibrate therapy in renal graft recipients. Lancet 1993; 341: 840.
26. Jespersen B, Tvedegaard E. Bezafibrate induced reduction of renal function in a renal transplant recipient. Nephrology, Dialysis, Transplantation 1995; 10: 702-3.
27. Ramachandran S, Giles PD, Hartland A. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment. British Medical Journal 1997; 314: 1593.
28. Panuccio V, Enia G, Parlongo S, Cutrupi S, Zoccali C. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. Nephron 1996; 73: 736.
29. Terrovitou CT, Milonis HJ, Elisaf MS. Acute rhabdomyolysis after bezafibrate re-exposure. Nephron 1998; 78: 336-7.
30. Wolfgang Rumpf K, Henning H. Rhabdomyolysis and Beta 2 adrenoceptor agonists. Nephron 1990; 55: 346-7.
31. Blake PG, Ryan F. Rhabdomyolysis and acute renal failure after terbutaline overdose. Nephron 1989; 53: 76-7.
32. Kendriefe WC, Hull AR, Knochel JP. Rhabdomyolysis and shock after intravenous amphetamine administration. Annals of Internal Medicine 1977; 6: 381-7.
33. Macdonald JB, Jones HM, Cowan RA. Rhabdomyolysis and acute renal failure after theophylline overdose. Lancet 1985; 1: 932-3.
34. Akmal M, Valdin JR, McCarron MM, Massry SG. Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication. American Journal of Nephrology 1981; 1: 91-6.
35. Cogen FC, Rigg G, Simmons JL, Domino EF. Phencyclidine-associated acute rhabdomyolysis. Annals of Internal Medicine 1978; 88: 210-12.
36. Hojs R, Sinkovic A. Rhabdomyolysis and acute renal failure following methadone overdose. Nephron 1992; 62: 362.
37. Melandri R, Re G, Lanzarini C, et al. Myocardial damage and rhabdomyolysis associated with prolonged hypoxic coma following opiate overdose. Journal of Toxicology - Clinical Toxicology 1996; 34: 199-203.
38. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoigne JJ, Acute rhabdomyolysis associated with cocaine intoxication. New England Journal of Medicine 1988; 319: 673-7.
39. Herzlich BC, Arsura EL, Pagala M, Grob D. Rhabdomyolysis related to cocaine abuse. Annals of Internal Medicine 1989; 110: 335-6.
40. Jandreski MA, Bermes EW, Leischer R, Kahn SE. Rhabdomyolysis in a free base cocaine ("crack") overdose. Clinical Chemistry 1989; 35: 1547-9
41. Cregler LL, Mark H. Medical complications of cocaine abuse. New England Journal of Medicine 1986; 315: 1495-500.
42. Horowitz BZ, Panacek EA, Jouriles NJ. Severe rhabdomyolysis with renal failure after intranasal cocaine use. Journal of Emergency Medicine 1997; 15: 833-7.
43. Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive and Critical Care Nursing 1997; 13: 216-23.
44. Dar KJ, McBrien ME. MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Medicine 1996; 9: 995-6.
45. Screaton GP, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL. Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet 1992; 339: 677-8.
46. Henry JA, Jeffrey KJ, Dawling S. Toxicity and deaths from 3,4-methylene dioxymetamphetamine ("ecstasy"). Lancet 1992; 340: 384-7.
47. Haller RG, Knochel JP. Skeletal muscle disease in alcoholism. Medical Clinics of North America 1984; 68: 91-103.
48. Song SK, Rubin E. Ethanol produces muscle damage in human volunteers. Science 1972; 175: 327-8.
49. Knochel JP, Schlein EM. On the mechanism of rhabdomyolysis in potassium depletion. Journal of Clinical Investigation 1972; 51: 1750-8.
50. Lamer AJ. Rhabdomyolysis and potassium. Nephrology, Dialysis, Transplantation 1995; 10: 300.
51. Lamer AJ. Potassium depletion and rhabdomyolysis. British Medical Journal 1994; 308: 136.
52. Riggs JE. Alcohol-associated rhabdomyolysis: ethanol induction of cytochrome P450 may potentiate myotoxicity. Clinical Neuropharmacology 1998; 21: 363-1.
53. Barrella M, Lauria G, Quatrale R, Paolino E. Hypokalaemic rhabdomyolysis associated with liquorice ingestion: report of an atypical case. Italian Journal of Neurological Sciences 1997; 18: 217-20.
54. Bateman AMS, Larner AJ, McCartney SA, Rifkin IR. Rhabdomyolysis associated with lithium-induced hyperosmolal state. Nephrology, Dialysis, Transplantation 1991; 6: 203-5.
55. Korzets Z, Zelter E, Bernheim J. Acute renal failure in the setting of the neuroleptic malignant syndrome. Nephrology, Dialysis, Transplantation 1996; 11: 885-6.
56. Rosenberg H, Fletcher JE. An update on malignant hyperpyrexia syndrome. Annals Academic Medicine Singapore 1994; 23 (supp): 84-97.
57. Sitprija V, Gopalakrishnakone P. Snake bite, rhabdomyolysis and renal failure. American Journal of Kidney Disease 1998; 31: 50-2.
58. Sutherland SK, King K. Management of snake bite injuries. 1991, Royal Flying Doctors Service of Australia.
59. Hong JJ, Lin JL, Wu MS, Huang CC, Verbeckmoes R. A chronic glue snifier with hypetchloraemia metabolic acidosis, rhabdomyolysis, irreversible quadriplegia, central pontine myelinolysis and hypothyroidism. Nephrology, Dialysis, Transplantation 1996; 11: 1848-9.
60. Florkowski CM, Rossi ML, Carey MP, Poulton K, Dickson GR, Ferner RE. Rhabdomyolysis and acute renal failure following carbon monoxide poisoning: two case reports with muscle histopathology and enzyme activities. Journal of Toxicology - Clinical Toxicology 1992; 30: 443-54
61. Lee CT, Wu MS, Lu K, Hsu KJ. Renal tubular acidosis, hypokalaemic paralysis, rhabdomyolysis and acute renal failure, a rare presentation of Chinese herbal nephropathy. Renal failure 1999; 21: 227-30.